Intravitreal Ranibizumab (Lucentis) for Neovascular Glaucoma- a Randomized Controlled Study
Latest Information Update: 16 Jan 2020
At a glance
- Drugs Ranibizumab (Primary)
- Indications Neovascular glaucoma
- Focus Therapeutic Use
- 30 Sep 2016 New trial record